These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2009537

  • 1. Expression of E- and P-cadherin in gastric carcinomas.
    Shimoyama Y, Hirohashi S.
    Cancer Res; 1991 Apr 15; 51(8):2185-92. PubMed ID: 2009537
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunohistochemical study of P-cadherin in breast cancer].
    Kovács A, Walker RA, Nagy A, Gomba S, Jones L, Dearing S.
    Orv Hetil; 2002 Feb 24; 143(8):405-9. PubMed ID: 11921707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN, Xu CP, Han B, Ji R.
    Ai Zheng; 2005 Oct 24; 24(10):1220-4. PubMed ID: 16219136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer.
    Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, Kawamura T, Miyazaki I, Endou Y, Tanaka M.
    Anal Cell Pathol; 1995 Mar 24; 8(2):177-90. PubMed ID: 7786814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Höfler H, Becker KF.
    Oncogene; 1999 Jul 29; 18(30):4301-12. PubMed ID: 10439038
    [Abstract] [Full Text] [Related]

  • 15. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C.
    Am J Pathol; 1995 Mar 29; 146(3):605-12. PubMed ID: 7534041
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D.
    Mod Pathol; 1998 Sep 29; 11(9):805-13. PubMed ID: 9758359
    [Abstract] [Full Text] [Related]

  • 18. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R, Mitze M, Frixen UH, Birchmeier W.
    Am J Pathol; 1993 Dec 29; 143(6):1731-42. PubMed ID: 8256859
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K.
    Br J Surg; 2002 Feb 29; 89(2):236-44. PubMed ID: 11856141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.